Spots Global Cancer Trial Database for fec
Every month we try and update this database with for fec cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | NCT00431080 | Breast Cancer | Docetaxel Paclitaxel Epirubicin Cyclophosphamid... 5-fluoruracil Granulocyte-col... | 18 Years - 75 Years | Hellenic Oncology Research Group | |
| Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | NCT00615602 | Breast Cancer | Docetaxel Trastuzumab Epirubicin Cyclophosphamid... 5-fluoruracil Granulocyte-col... Trastuzumab | 18 Years - 75 Years | Hellenic Oncology Research Group | |
| Adjuvant FEC Versus EP in Breast Cancer (MIG5) | NCT02450058 | Breast Cancer Chemotherapy, A... | 5-fluorouracil epirubicin cyclophosphamid... epirubicin paclitaxel | 18 Years - 70 Years | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | NCT00431080 | Breast Cancer | Docetaxel Paclitaxel Epirubicin Cyclophosphamid... 5-fluoruracil Granulocyte-col... | 18 Years - 75 Years | Hellenic Oncology Research Group | |
| Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer | NCT00520546 | Prostate Cancer | 18F-Ethylcholin... Endorectal Magn... | 50 Years - | German Federal Armed Forces | |
| Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | NCT00038402 | Breast Cancer | Herceptin Taxol Fluorouracil Cytoxan Epirubicin | - | M.D. Anderson Cancer Center | |
| A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer | NCT00976989 | Breast Cancer | Pertuzumab Trastuzumab FEC Docetaxel TCH | 18 Years - | Hoffmann-La Roche | |
| Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer | NCT03879577 | Breast Cancer Breast Cancer F... HER2-positive B... Breast Cancer S... Breast Cancer S... | Docetaxel Herceptin FEC Tamoxifen Letrozole LHRH agonist | 18 Years - 70 Years | University of Chicago | |
| Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer | NCT00520546 | Prostate Cancer | 18F-Ethylcholin... Endorectal Magn... | 50 Years - | German Federal Armed Forces | |
| A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer | NCT00976989 | Breast Cancer | Pertuzumab Trastuzumab FEC Docetaxel TCH | 18 Years - | Hoffmann-La Roche | |
| Adjuvant FEC Versus EP in Breast Cancer (MIG5) | NCT02450058 | Breast Cancer Chemotherapy, A... | 5-fluorouracil epirubicin cyclophosphamid... epirubicin paclitaxel | 18 Years - 70 Years | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer | NCT03058939 | Breast Cancer Breast Cancer S... Breast Cancer S... | Paclitaxel Perjeta Herceptin SC Tamoxifen Letrozole LHRH agonist FEC Carboplatin | 18 Years - 70 Years | University of Chicago | |
| Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | NCT01985724 | Breast Cancer | Docetaxel Epirubicin Cyclophosphamid... 5-fluoruracil Granulocyte-col... | 18 Years - | Hellenic Oncology Research Group | |
| Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer | NCT01036087 | Breast Cancer | Panitumumab Nab-paclitaxel Carboplatin 5-Fluorouracil Epirubicin Cyclophosphamid... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
